Merck & Co Inc

NYSE: MRK
$117.17
-$0.06 (-0.1%)
Closing Price on September 20, 2024

MRK Articles

24/7 Wall St. has put together a preview of the two Dow stocks scheduled to report their quarterly results on Thursday: Merck and Visa.
Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the index has made since the Trump rally began and push it even further beyond 20,000.
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
GE, Merck, Boeing, and Exxon Mobil lead the DJIA to a small loss on Monday.
Merck, P&G, IBM, and Exxon Mobil lift DJIA by more than 75 points on Friday.
Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.
Oddly, perhaps, the best performing stock in the first two weeks of the year is drug maker Merck.
The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed to find itself as a top pick for pharmaceutical and biohealth analysts.
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
The the top analyst upgrades, downgrades and initiations on Thursday include AK Steel, Merck, Twitter, U.S. Steel, Walt Disney and Xerox.
Merck, Intel, IBM, Goldman Sachs lead Dow Jones Industrial Average higher Wednesday.
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and a slight move. Although...
The DJIA bull-bear projection of 21,422 would be short of the preliminary look of 22,000 seen at the end of December, but another 8.4% gain likely would be more than welcome.
There is an investment vehicle that may offer investors a way to stay in equities, get paid solid dividends and have the potential for outperforming total return.
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.